Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-26 @ 1:16 PM
Study NCT ID:
NCT03518606
Status:
COMPLETED
Last Update Posted:
2025-01-15
First Post:
2018-04-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
Sponsor:
UNICANCER
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-23
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-13
Last Update Post Date:
2025-01-15
Last Update Post Date Type:
ACTUAL